Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 333

1.

VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma.

Martini M, de Pascalis I, D'Alessandris QG, Fiorentino V, Pierconti F, Marei HE, Ricci-Vitiani L, Pallini R, Larocca LM.

BMC Cancer. 2018 May 10;18(1):553. doi: 10.1186/s12885-018-4442-2.

2.

Endothelial trans-differentiation in glioblastoma recurring after radiotherapy.

De Pascalis I, Morgante L, Pacioni S, D'Alessandris QG, Giannetti S, Martini M, Ricci-Vitiani L, Malinverno M, Dejana E, Larocca LM, Pallini R.

Mod Pathol. 2018 Apr 30. doi: 10.1038/s41379-018-0046-2. [Epub ahead of print]

PMID:
29713042
3.

Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules.

Rossi ED, Martini M, Capodimonti S, Cenci T, Bilotta M, Pierconti F, Pontecorvi A, Lombardi CP, Fadda G, Larocca LM.

Cytopathology. 2018 Apr 23. doi: 10.1111/cyt.12555. [Epub ahead of print]

PMID:
29683529
4.

Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents.

Calvaruso V, Cabibbo G, Cacciola I, Petta S, Madonia S, Bellia A, Tinè F, Distefano M, Licata A, Giannitrapani L, Prestileo T, Mazzola G, Di Rosolini MA, Larocca L, Bertino G, Digiacomo A, Benanti F, Guarneri L, Averna A, Iacobello C, Magro A, Scalisi I, Cartabellotta F, Savalli F, Barbara M, Davì A, Russello M, Scifo G, Squadrito G, Cammà C, Raimondo G, Craxì A, Di Marco V; Rete Sicilia Selezione Terapia–HCV (RESIST-HCV).

Gastroenterology. 2018 Apr 12. pii: S0016-5085(18)30441-4. doi: 10.1053/j.gastro.2018.04.008. [Epub ahead of print]

PMID:
29655836
5.

Nurse liaison: a strategy for counter-referral.

Ribas EDN, Bernardino E, Larocca LM, Poli Neto P, Aued GK, Silva CPCD.

Rev Bras Enferm. 2018;71(suppl 1):546-553. doi: 10.1590/0034-7167-2017-0490. English, Portuguese.

6.

Erlotinib for Patients with EGFR Wild-Type Metastatic NSCLC: a Retrospective Biomarkers Analysis.

Inno A, Di Noia V, Martini M, D'Argento E, Di Salvatore M, Arena V, Schinzari G, Orlandi A, Larocca LM, Cassano A, Barone C.

Pathol Oncol Res. 2018 Mar 20. doi: 10.1007/s12253-018-0404-x. [Epub ahead of print]

PMID:
29557085
7.

Corrigendum to "Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy)" [Pathol. Res. Pract. 213 (2017) 1078-1081].

Pierconti F, Straccia P, Emilio S, Bassi PF, De Pascalis I, Marques RC, Volavsek M, Larocca LM, Lopez-Beltran A.

Pathol Res Pract. 2018 Apr;214(4):603. doi: 10.1016/j.prp.2018.03.012. Epub 2018 Mar 15. No abstract available.

PMID:
29549984
8.

To Obtain More With Less: Cytologic Samples With Ancillary Molecular Techniques-The Useful Role of Liquid-Based Cytology.

Martini M, Capodimonti S, Cenci T, Bilotta M, Fadda G, Larocca LM, Rossi ED.

Arch Pathol Lab Med. 2018 Mar;142(3):299-307. doi: 10.5858/arpa.2017-0148-RA.

PMID:
29494225
9.

Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia.

Innocenti I, Rossi D, Trapè G, Autore F, Larocca LM, Gomes V, Cerri M, Falcucci P, Sica S, Gaidano G, Laurenti L.

Hematol Oncol. 2018 Feb 27. doi: 10.1002/hon.2502. [Epub ahead of print]

PMID:
29484684
10.

Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.

Spina V, Bruscaggin A, Cuccaro A, Martini M, Di Trani M, Forestieri G, Manzoni M, Condoluci A, Arribas A, Terzi-Di-Bergamo L, Locatelli SL, Cupelli E, Ceriani L, Moccia AA, Stathis A, Nassi L, Deambrogi C, Diop F, Guidetti F, Cocomazzi A, Annunziata S, Rufini V, Giordano A, Neri A, Boldorini R, Gerber B, Bertoni F, Ghielmini M, Stüssi G, Santoro A, Cavalli F, Zucca E, Larocca LM, Gaidano G, Hohaus S, Carlo-Stella C, Rossi D.

Blood. 2018 May 31;131(22):2413-2425. doi: 10.1182/blood-2017-11-812073. Epub 2018 Feb 15.

PMID:
29449275
11.

The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration.

Pierconti F, Rossi ED, Straccia P, Fadda G, Larocca LM, Bassi PF, Sacco E, Schinzari G.

Cancer Cytopathol. 2018 Mar;126(3):200-206. doi: 10.1002/cncy.21957. Epub 2018 Jan 23.

PMID:
29360198
12.

34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts.

Pierconti F, Rossi ED, Martini M, Sacco E, Bassi PF, Larocca LM.

Appl Immunohistochem Mol Morphol. 2018 Jan 16. doi: 10.1097/PAI.0000000000000599. [Epub ahead of print]

PMID:
29346181
13.

Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy.

Hohaus S, Tisi MC, Bellesi S, Maiolo E, Alma E, Tartaglia G, Corrente F, Cuccaro A, D'Alo' F, Basile U, Larocca LM, De Stefano V.

Cancer Med. 2018 Jan;7(1):270-281. doi: 10.1002/cam4.1166. Epub 2017 Dec 22.

14.

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age group.

Rossi ED, Mehrotra S, Kilic AI, Toslak IE, Lim-Dunham J, Martini M, Fadda G, Lombardi CP, Larocca LM, Barkan GA.

Cancer Cytopathol. 2018 Jan;126(1):27-35. doi: 10.1002/cncy.21933. Epub 2017 Oct 12.

PMID:
29024469
15.

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).

Zhou H, Baloch ZW, Nayar R, Bizzarro T, Fadda G, Adhikari-Guragain D, Hatem J, Larocca LM, Samolczyk J, Slade J, Rossi ED.

Cancer Cytopathol. 2018 Jan;126(1):20-26. doi: 10.1002/cncy.21926. Epub 2017 Sep 20.

PMID:
28941185
16.

Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy).

Pierconti F, Straccia P, Emilio S, Bassi PF, De Pascalis I, Marques RC, Volavsek M, Larocca LM, Lopez-Beltran A.

Pathol Res Pract. 2017 Sep;213(9):1078-1081. doi: 10.1016/j.prp.2017.07.026. Epub 2017 Aug 1. Erratum in: Pathol Res Pract. 2018 Mar 14;:.

PMID:
28843746
17.

Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study.

Cabibbo G, Petta S, Calvaruso V, Cacciola I, Cannavò MR, Madonia S, Distefano M, Larocca L, Prestileo T, Tinè F, Bertino G, Giannitrapani L, Benanti F, Licata A, Scalisi I, Mazzola G, Cartabellotta F, Alessi N, Barbàra M, Russello M, Scifo G, Squadrito G, Raimondo G, Craxì A, Di Marco V, Cammà C; Rete Sicilia Selezione Terapia - HCV (RESIST-HCV).

Aliment Pharmacol Ther. 2017 Oct;46(7):688-695. doi: 10.1111/apt.14256. Epub 2017 Aug 9.

PMID:
28791711
18.

When Somatic Mutations Are Associated With a Higher Aggressive Behavior-A Story of Announced Evidence.

Rossi ED, Martini M, Larocca LM.

JAMA Oncol. 2017 Oct 1;3(10):1427-1428. doi: 10.1001/jamaoncol.2017.1510. No abstract available.

PMID:
28617899
19.

The role of thyroid FNA cytology in pediatric malignant lesions: An overview of the literature.

Rossi ED, Martini M, Cenci T, Capodimonti S, Larocca LM.

Cancer Cytopathol. 2017 Aug;125(8):594-603. doi: 10.1002/cncy.21884. Epub 2017 Jun 5. Review.

PMID:
28581673
20.

RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases.

Brudvik KW, Jones RP, Giuliante F, Shindoh J, Passot G, Chung MH, Song J, Li L, Dagenborg VJ, Fretland ÅA, Røsok B, De Rose AM, Ardito F, Edwin B, Panettieri E, Larocca LM, Yamashita S, Conrad C, Aloia TA, Poston GJ, Bjørnbeth BA, Vauthey JN.

Ann Surg. 2017 May 25. doi: 10.1097/SLA.0000000000002319. [Epub ahead of print]

PMID:
28549012
21.

A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation.

Calegari MA, Inno A, Monterisi S, Orlandi A, Santini D, Basso M, Cassano A, Martini M, Cenci T, de Pascalis I, Camarda F, Barbaro B, Larocca LM, Gori S, Tonini G, Barone C.

Br J Cancer. 2017 May 9;116(10):1279-1286. doi: 10.1038/bjc.2017.109. Epub 2017 Apr 20.

22.

The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response.

D'Alessandris QG, Biffoni M, Martini M, Runci D, Buccarelli M, Cenci T, Signore M, Stancato L, Olivi A, De Maria R, Larocca LM, Ricci-Vitiani L, Pallini R.

Neuro Oncol. 2017 Aug 1;19(8):1097-1108. doi: 10.1093/neuonc/now304.

PMID:
28204560
23.

SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.

Pierconti F, Martini M, Cenci T, Petrone GL, Ricci R, Sacco E, Bassi PF, Larocca LM.

Prostate. 2017 May;77(6):597-603. doi: 10.1002/pros.23299. Epub 2017 Feb 1.

PMID:
28144985
24.

Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome.

Cesarini V, Martini M, Vitiani LR, Gravina GL, Di Agostino S, Graziani G, D'Alessandris QG, Pallini R, Larocca LM, Rossi P, Jannini EA, Dolci S.

Oncotarget. 2017 Feb 21;8(8):13223-13239. doi: 10.18632/oncotarget.14656.

25.

Impaired functional responses in follicular lymphoma CD8+TIM-3+ T lymphocytes following TCR engagement.

Gravelle P, Do C, Franchet C, Mueller S, Oberic L, Ysebaert L, Larocca LM, Hohaus S, Calmels MN, Frenois FX, Kridel R, Gascoyne RD, Laurent G, Brousset P, Valitutti S, Laurent C.

Oncoimmunology. 2016 Aug 24;5(10):e1224044. eCollection 2016.

26.

Cytopathology of Follicular Cell Nodules.

Rossi ED, Bizzarro T, Martini M, Larocca LM, Schmitt F, Vielh P.

Adv Anat Pathol. 2017 Jan;24(1):45-55. Review.

PMID:
27941541
27.

The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies With Aggressive Behavior.

Pierconti F, Martini M, Cenci T, Larocca LM.

Appl Immunohistochem Mol Morphol. 2018 May/Jun;26(5):324-329. doi: 10.1097/PAI.0000000000000438.

PMID:
27801727
28.
29.

Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification.

Bizzarro T, Martini M, Capodimonti S, Straccia P, Lombardi CP, Pontecorvi A, Larocca LM, Rossi ED.

Cancer Cytopathol. 2016 Oct;124(10):699-710. doi: 10.1002/cncy.21777. Epub 2016 Sep 26.

30.

Nursing terminology as a work process instrument of nurses in collective health.

Cavalcante MD, Larocca LM, Chaves MM, Cubas MR, Piosiadlo LC, Mazza VA.

Rev Esc Enferm USP. 2016 Jul-Aug;50(4):610-616. doi: 10.1590/S0080-623420160000500010. English, Portuguese.

31.

Tool and ideological knowledge in Street Outreach Office working process.

Kami MT, Larocca LM, Chaves MM, Piosiadlo LC, Albuquerque GS.

Rev Esc Enferm USP. 2016 May-Jun;50(3):442-9. doi: 10.1590/S0080-623420160000400010. English, Portuguese.

32.

Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study.

Adler M, Larocca L, Trovato FM, Marcinkowski H, Pasha Y, Taylor-Robinson SD.

HPB (Oxford). 2016 Aug;18(8):678-83. doi: 10.1016/j.hpb.2016.05.005. Epub 2016 Jun 9.

33.

The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF V600E mutation.

Rossi ED, Bizzarro T, Granja S, Martini M, Capodimonti S, Luca E, Fadda G, Lombardi CP, Pontecorvi A, Larocca LM, Baltazar F, Schmitt F.

Endocrine. 2017 May;56(2):379-387. doi: 10.1007/s12020-016-1044-0. Epub 2016 Aug 2.

PMID:
27484771
34.

Divergent gastrointestinal stromal tumors in syndromic settings.

Ricci R, Martini M, Cenci T, Riccioni ME, Maria G, Cassano A, Larocca LM.

Cancer Genet. 2016 Jul-Aug;209(7-8):354-8. doi: 10.1016/j.cancergen.2016.05.073. Epub 2016 May 27.

PMID:
27318444
35.

Morphological features that can predict BRAFV600E -mutated carcinoma in paediatric thyroid cytology.

Rossi ED, Bizzarro T, Martini M, Capodimonti S, Cenci T, Fadda G, Schmitt F, Larocca LM.

Cytopathology. 2017 Feb;28(1):55-64. doi: 10.1111/cyt.12350. Epub 2016 Jun 3.

PMID:
27256275
36.

Novel cruzipain inhibitors for the chemotherapy of chronic Chagas disease.

Sbaraglini ML, Bellera CL, Fraccaroli L, Larocca L, Carrillo C, Talevi A, Alba Soto CD.

Int J Antimicrob Agents. 2016 Jul;48(1):91-5. doi: 10.1016/j.ijantimicag.2016.02.018. Epub 2016 Apr 22.

PMID:
27216381
37.

Human cord blood endothelial progenitors promote post-ischemic angiogenesis in immunocompetent mouse model.

Flex A, Biscetti F, Iachininoto MG, Nuzzolo ER, Orlando N, Capodimonti S, Angelini F, Valentini CG, Bianchi M, Larocca LM, Martini M, Teofili L.

Thromb Res. 2016 May;141:106-11. doi: 10.1016/j.thromres.2016.03.012. Epub 2016 Mar 10.

PMID:
26994683
38.

The role of fine-needle aspiration in the thyroid nodules of elderly patients.

Rossi ED, Bizzarro T, Martini M, Straccia P, Lombardi CP, Pontecorvi A, Larocca LM, Fadda G.

Oncotarget. 2016 Mar 15;7(11):11850-9. doi: 10.18632/oncotarget.7643.

39.

Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome.

Marziali G, Signore M, Buccarelli M, Grande S, Palma A, Biffoni M, Rosi A, D'Alessandris QG, Martini M, Larocca LM, De Maria R, Pallini R, Ricci-Vitiani L.

Sci Rep. 2016 Feb 9;6:21557. doi: 10.1038/srep21557.

40.

Endothelial Cells Lining Sporadic Cerebral Cavernous Malformation Cavernomas Undergo Endothelial-to-Mesenchymal Transition.

Bravi L, Malinverno M, Pisati F, Rudini N, Cuttano R, Pallini R, Martini M, Larocca LM, Locatelli M, Levi V, Bertani GA, Dejana E, Lampugnani MG.

Stroke. 2016 Mar;47(3):886-90. doi: 10.1161/STROKEAHA.115.011867. Epub 2016 Feb 2.

41.

The evaluation of miRNAs on thyroid FNAC: the promising role of miR-375 in follicular neoplasms.

Rossi ED, Bizzarro T, Martini M, Capodimonti S, Sarti D, Cenci T, Bilotta M, Fadda G, Larocca LM.

Endocrine. 2016 Dec;54(3):723-732. doi: 10.1007/s12020-016-0866-0. Epub 2016 Jan 27.

PMID:
26818914
42.

CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma.

Cuccaro A, Annunziata S, Cupelli E, Martini M, Calcagni ML, Rufini V, Giachelia M, Bartolomei F, Galli E, D'Alò F, Voso MT, Leone G, Giordano A, Larocca LM, Hohaus S.

Cancer Med. 2016 Mar;5(3):398-406. doi: 10.1002/cam4.585. Epub 2016 Jan 13.

43.

Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse.

Orlandi A, Calegari MA, Martini M, Cocomazzi A, Bagalà C, Indellicati G, Zurlo V, Basso M, Cassano A, Larocca LM, Barone C.

Clin Transl Oncol. 2016 Oct;18(10):988-95. doi: 10.1007/s12094-015-1471-z. Epub 2016 Jan 7.

PMID:
26742940
44.

An abnormal secretion of soluble mediators contributes to the hematopoietic-niche dysfunction in low-risk myelodysplastic syndrome.

Martini M, Capodimonti S, Iachininoto MG, Cocomazzi A, Nuzzolo ER, Voso MT, Teofili L, Larocca LM.

Blood Cancer J. 2015 Nov 27;5:e370. doi: 10.1038/bcj.2015.97. No abstract available.

45.

Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.

Tisi MC, Cupelli E, Santangelo R, Maiolo E, Alma E, Giachelia M, Martini M, Bellesi S, D'Alò F, Voso MT, Pompili M, Leone G, Larocca LM, Hohaus S.

Leuk Lymphoma. 2016;57(3):628-34. doi: 10.3109/10428194.2015.1072766. Epub 2015 Oct 12.

PMID:
26458141
46.

miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.

Lulli V, Buccarelli M, Martini M, Signore M, Biffoni M, Giannetti S, Morgante L, Marziali G, Ilari R, Pagliuca A, Larocca LM, De Maria R, Pallini R, Ricci-Vitiani L.

Oncotarget. 2015 Nov 10;6(35):37241-56. doi: 10.18632/oncotarget.5925.

47.

Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.

Rossi ED, Martini M, Bizzarro T, Capodimonti S, Cenci T, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM.

Cancer Cytopathol. 2015 Oct;123(10):593-602. doi: 10.1002/cncy.21586. Epub 2015 Jul 31.

48.

The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology.

Bizzarro T, Martini M, Marrocco C, D'Amato D, Traini E, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM, Rossi ED.

PLoS One. 2015 Jul 17;10(7):e0132939. doi: 10.1371/journal.pone.0132939. eCollection 2015.

49.

Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease.

Piscaglia AC, Rutella S, Laterza L, Cesario V, Campanale M, Cazzato IA, Ianiro G, Barbaro F, Di Maurizio L, Bonanno G, Cenci T, Cammarota G, Larocca LM, Gasbarrini A.

J Transl Med. 2015 Jul 11;13:220. doi: 10.1186/s12967-015-0591-0.

50.

Fanconi anemia gene variants in therapy-related myeloid neoplasms.

Voso MT, Fabiani E, Zang Z, Fianchi L, Falconi G, Padella A, Martini M, Li Zhang S, Santangelo R, Larocca LM, Criscuolo M, La Brocca A, Cutcutache I, Rozen S, Simonetti G, Manfrini M, Martinelli G, Hohaus S, Leone G, Tan P, Tenen DG.

Blood Cancer J. 2015 Jul 3;5:e323. doi: 10.1038/bcj.2015.44. No abstract available.

Supplemental Content

Loading ...
Support Center